These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32701043)

  • 21. Ibrutinib for Chronic Lymphocytic Leukemia.
    Ruchlemer R; Ben Ami R; Lachish T
    N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
    [No Abstract]   [Full Text] [Related]  

  • 22. Ibrutinib for Chronic Lymphocytic Leukemia.
    Rigolin GM; Cavazzini F; Cuneo A
    N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
    [No Abstract]   [Full Text] [Related]  

  • 23. Ibrutinib for Chronic Lymphocytic Leukemia.
    Sharman JP; Mato AR; Keating MJ
    N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
    [No Abstract]   [Full Text] [Related]  

  • 24. Ibrutinib for Chronic Lymphocytic Leukemia.
    Burger JA; Styles L; Kipps TJ
    N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ibrutinib in the treatment of chronic lymphocytic leukemia and other B-cell malignancies].
    Wang M; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):245-9. PubMed ID: 24598688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibrutinib and its use in the treatment of chronic lymphocytic leukemia.
    Frustaci AM; Tedeschi A; Deodato M; Mazzucchelli M; Cairoli R; Montillo M
    Future Oncol; 2018 Apr; 14(8):681-697. PubMed ID: 29243946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ibrutinib - new tool in hematologist hand, new challenges for internist].
    Majcherek M; Dworacka M; Dworacki G
    Wiad Lek; 2017; 70(1):92-95. PubMed ID: 28343201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia.
    Manda S; Dunbar N; Marx-Wood CR; Danilov AV
    Br J Haematol; 2015 Sep; 170(5):734-6. PubMed ID: 25716177
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances and challenges in the early diagnosis and management of invasive fungal infections in Africa.
    Ibe C; Otu AA
    FEMS Yeast Res; 2022 Oct; 22(1):. PubMed ID: 36259762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining Invasive Fungal Diseases for Clinical Research: A Work in Progress.
    Rogers TR
    Clin Infect Dis; 2020 Sep; 71(6):1377-1378. PubMed ID: 31802113
    [No Abstract]   [Full Text] [Related]  

  • 31. Ibrutinib in relapsed chronic lymphocytic leukemia.
    Neffendorf JE; Gout I; Hildebrand GD
    N Engl J Med; 2013 Sep; 369(13):1277. PubMed ID: 24066759
    [No Abstract]   [Full Text] [Related]  

  • 32. Ibrutinib in relapsed chronic lymphocytic leukemia.
    Byrd JC; O'Brien S; James DF
    N Engl J Med; 2013 Sep; 369(13):1278-9. PubMed ID: 24066758
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical safety of ibrutinib in chronic lymphocytic leukemia.
    Molica S
    Expert Opin Drug Saf; 2015 Oct; 14(10):1621-9. PubMed ID: 26359217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia--response to Rider et al.
    Danilov AV
    Br J Haematol; 2016 Apr; 173(2):327-8. PubMed ID: 26195155
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia in a patient with well-controlled HIV infection: successful treatment with ibrutinib.
    England JT; Leitch HA
    Leuk Lymphoma; 2018 Mar; 59(3):752-754. PubMed ID: 28728450
    [No Abstract]   [Full Text] [Related]  

  • 36. Ibrutinib (Imbruvica) for chronic lymphocytic leukemia.
    Med Lett Drugs Ther; 2014 Apr; 56(1440):29-30. PubMed ID: 24736247
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?
    Gaye E; Le Bot A; Talarmin JP; Le Calloch R; Belaz S; Dupont M; Tattevin P
    Med Mal Infect; 2018 Jun; 48(4):294-297. PubMed ID: 29402474
    [No Abstract]   [Full Text] [Related]  

  • 38. Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.
    Kolomeyer AM; Hwang CK; Kim BJ
    J Med Case Rep; 2018 Nov; 12(1):349. PubMed ID: 30442199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison.
    Andrasiak I; Rybka J; Knopinska-Posluszny W; Wrobel T
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):268-273. PubMed ID: 28395851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia.
    Wang SY; Ebert T; Jaekel N; Schubert S; Niederwieser D; Al-Ali HK
    Ann Hematol; 2015 Aug; 94(8):1419-20. PubMed ID: 25903044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.